MTZPY - Mitsubishi Tanabe Pharma Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 59.9B
Enterprise value 39.79B
Trailing P/E 20.52
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)1.20
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 331.31%
S&P500 52-week change 3-12.65%
52-week high 318.80
52-week low 310.59
50-day moving average 317.52
200-day moving average 315.92

Share statistics

Avg vol (3-month) 318.91k
Avg vol (10-day) 317.74k
Shares outstanding 5560.78M
Float 560.78M
% held by insiders 10.00%
% held by institutions 10.16%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.51
Forward annual dividend yield 42.93%
Trailing annual dividend rate 30.51
Trailing annual dividend yield 32.88%
5-year average dividend yield 42.78
Payout ratio 4224.43%
Dividend date 3N/A
Ex-dividend date 425-Sep-2019
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30-Mar-2019
Most-recent quarter (mrq)30-Dec-2019

Profitability

Profit margin 3.62%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)1.44%
Return on equity (ttm)1.06%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)-11.00%
Gross profit (ttm)244.12B
EBITDA N/A
Net income avi to common (ttm)N/A
Diluted EPS (ttm)0.86
Quarterly earnings growth (yoy)-39.90%

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)0.22
Current ratio (mrq)6.05
Book value per share (mrq)14.71

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A